State of Wyoming’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-3,104
Closed -$56.6K 1738
2023
Q1
$56.6K Buy
3,104
+804
+35% +$15.4K 0.02% 1065
2022
Q4
$47.6K Buy
+2,300
New +$63.3K 0.02% 1088
2022
Q3
Sell
-1,611
Closed -$41K 1861
2022
Q2
$41K Buy
1,611
+788
+96% +$19.3K 0.03% 1072
2022
Q1
$26K Buy
+823
New +$27.6K 0.01% 1369
2021
Q2
Sell
-3
Closed 1213
2021
Q1
$0 Buy
+3
New +$104 ﹤0.01% 542

Other funds holding RCUS

State of Wyoming's RCUS Position: Q2 2023 in Review

State of Wyoming sold out of Arcus Biosciences (RCUS) in Q2 2023, closing a stake of 3,104 shares — an estimated $56.6K sold.

State of Wyoming first reported a position in RCUS in Q1 2021 and held it in 5 quarters. The position peaked at $56.6K in Q1 2023. 181 funds tracked by Wall St. Rank hold RCUS as of Q2 2023.

  • State of Wyoming reported no remaining Arcus Biosciences position as of Q2 2023 after selling out during the quarter.
  • State of Wyoming sold 3,104 Arcus Biosciences shares in Q2 2023, an estimated $56.6K.
  • State of Wyoming first reported a position in Arcus Biosciences in Q1 2021 and held it in 5 quarters.
  • State of Wyoming's Arcus Biosciences position peaked at $56.6K in Q1 2023.
  • 181 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2023.

Based on State of Wyoming's 13F filing for Q2 2023, filed 14 Aug 2023.